Literature DB >> 29115823

An Overview of the Clinical Uses, Pharmacology, and Safety of Modafinil.

Eric Murillo-Rodríguez1,2,3, André Barciela Veras3,4,5, Nuno Barbosa Rocha3,6, Henning Budde3,7,8,9, Sérgio Machado3,5,10.   

Abstract

Modafinil (MOD) is a wakefulness-inducing compound prescribed for treatment of excessive daytime sleepiness as a consequence of sleep disturbances such as shift work sleep disorder, obstructive sleep apnea, restless leg syndrome, or narcolepsy. While providing effective results in patients with sleepiness, MOD also produces positive outcomes in the management of fatigue associated with different conditions including depression, cancer, or tiredness in military personnel. Although there is clear evidence of the stimulant effects of MOD, current data also show that administration of this drug apparently induces positive neurobiological effects, such as improvement in memory. However, serious concerns have been raised since some reports have suggested MOD dependence. Taken together, these findings highlight the need to characterize the changes induced by MOD which have been observed in several neurobiological functions. Moreover, further work should follow up on the likely long-term effects of this drug if used for treatment of drowsiness and tiredness. Here, we review and summarize recent findings of the medical uses of MOD in the management of sleepiness and fatigue associated with depression or cancer as well as exhaustion in military personnel. We also discuss the available literature related with the cognitive enhancing properties of this stimulant, as well as what is known and unknown about MOD addiction.

Entities:  

Keywords:  Sleep; addiction; dopamine; drug; hypocretin; treatment

Mesh:

Substances:

Year:  2017        PMID: 29115823     DOI: 10.1021/acschemneuro.7b00374

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  14 in total

1.  Noradrenergic α1-Adrenoceptor Actions in the Primate Dorsolateral Prefrontal Cortex.

Authors:  Dibyadeep Datta; Sheng-Tao Yang; Veronica C Galvin; John Solder; Fei Luo; Yury M Morozov; Jon Arellano; Alvaro Duque; Pasko Rakic; Amy F T Arnsten; Min Wang
Journal:  J Neurosci       Date:  2019-02-12       Impact factor: 6.167

2.  Natural Cannabinoids as Templates for Sleep Disturbances Treatments.

Authors:  Eric Murillo-Rodríguez; Sérgio Machado; Claudio Imperatori; Tetsuya Yamamoto; Henning Budde
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 3.  Benefits and Harms of 'Smart Drugs' (Nootropics) in Healthy Individuals.

Authors:  Fabrizio Schifano; Valeria Catalani; Safia Sharif; Flavia Napoletano; John Martin Corkery; Davide Arillotta; Suzanne Fergus; Alessandro Vento; Amira Guirguis
Journal:  Drugs       Date:  2022-04-02       Impact factor: 9.546

Review 4.  Diagnosis and management of sleep disorders in Prader-Willi syndrome.

Authors:  Jessica Duis; Lara C Pullen; Maria Picone; Norman Friedman; Stephen Hawkins; Elise Sannar; Anna C Pfalzer; Althea Robinson Shelton; Deepan Singh; Phyllis C Zee; Daniel G Glaze; Amee Revana
Journal:  J Clin Sleep Med       Date:  2022-06-01       Impact factor: 4.324

5.  Evaluation of Urea-Based Inhibitors of the Dopamine Transporter Using the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis.

Authors:  Md Ashraf-Uz-Zaman; Guangchen Ji; Dalton Tidwell; Linda Yin; Smathorn Thakolwiboon; Jie Pan; Riley Junell; Zach Griffin; Sadisna Shahi; Derek Barthels; Md Sanaullah Sajib; Paul C Trippier; Constantinos M Mikelis; Hiranmoy Das; Mirla Avila; Volker Neugebauer; Nadezhda A German
Journal:  ACS Chem Neurosci       Date:  2022-01-03       Impact factor: 5.780

6.  Structure-activity relationships for a series of (Bis(4-fluorophenyl)methyl)sulfinylethyl-aminopiperidines and -piperidine amines at the dopamine transporter: Bioisosteric replacement of the piperazine improves metabolic stability.

Authors:  JoLynn B Giancola; Alessandro Bonifazi; Jianjing Cao; Therese Ku; Alexandra J Haraczy; Jenny Lam; Rana Rais; Mark A Coggiano; Gianluigi Tanda; Amy Hauck Newman
Journal:  Eur J Med Chem       Date:  2020-08-09       Impact factor: 6.514

Review 7.  Idiopathic Hypersomnia and Other Hypersomnia Syndromes.

Authors:  Lynn Marie Trotti; Isabelle Arnulf
Journal:  Neurotherapeutics       Date:  2021-01       Impact factor: 7.620

Review 8.  Central Disorders of Hypersomnolence.

Authors:  Lynn Marie Trotti
Journal:  Continuum (Minneap Minn)       Date:  2020-08

9.  Operant Assessment of DMTP Spatial Working Memory in Mice.

Authors:  Jasper Teutsch; Dennis Kätzel
Journal:  Front Behav Neurosci       Date:  2019-08-27       Impact factor: 3.558

10.  Wake-Promoting and EEG Spectral Effects of Modafinil After Acute or Chronic Administration in the R6/2 Mouse Model of Huntington's Disease.

Authors:  Szilvia Vas; Jackie M Casey; Will T Schneider; Lajos Kalmar; A Jennifer Morton
Journal:  Neurotherapeutics       Date:  2020-07       Impact factor: 6.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.